Epoxyeicosatrienoic acid

From WikiMD's WELLNESSPEDIA

Epoxyeicosatrienoic acid (EETs) are signaling molecules produced within the body from arachidonic acid by the action of cytochrome P450 enzymes. They are part of the eicosanoid family of fatty acids, which play a role in inflammation, immunity, and other bodily functions.

Production and Metabolism[edit]

EETs are produced from arachidonic acid, a polyunsaturated fatty acid, by the action of cytochrome P450 enzymes. These enzymes are found in many tissues throughout the body, including the liver, kidneys, and heart. Once produced, EETs can be further metabolized by soluble epoxide hydrolase (sEH), which converts them into less active dihydroxyeicosatrienoic acids (DHETs).

Biological Functions[edit]

EETs have a wide range of biological functions. They are involved in the regulation of vascular tone, inflammation, and blood clotting. They also play a role in the protection of the heart during ischemic events, such as a heart attack. In addition, EETs have been shown to promote the growth of new blood vessels, a process known as angiogenesis.

Clinical Significance[edit]

Due to their role in inflammation and vascular regulation, EETs have been implicated in a number of diseases, including hypertension, atherosclerosis, and diabetes. Inhibitors of sEH, which increase the levels of EETs, are currently being investigated as potential treatments for these conditions.

See Also[edit]



This physiology-related article is a stub. You can help WikiMD by expanding it.

Epoxyeicosatrienoic acid[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.